Clinical trials in nuclear medicine. Sorted by date of last update.
Study to Evaluate the Efficacy and Safety of [Lu-177]Lu-DOTA-TATE in Patients with Grade 1 and Grade 2 Advanced GEP-NET (NETTER-3)
Phase 3
Last update: October 21
Dose Finding Study of [Lu-177]Lu-NeoB in Newly Diagnosed Glioblastoma and in Recurrent Glioblastoma
Phase 1
A Phase II Study of AAA617 Alone and AAA617 in Combination with ARPI in Patients with PSMA PET Scan Positive CRPC (PSMACare)
Phase 2
177^Lu-PSMA-617 in Combination with Sipuleucel-T for the Treatment of Metastatic Castration-Resistant Prostate Cancer
Testing the Effectiveness of an Anti-cancer Drug, Triapine, When Used with Targeted Radiation-based Treatment (Lutetium Lu-177 Dotatate), Compared to Lutetium Lu-177 Dotatate Alone for Metastatic Neuroendocrine Tumors
Lu-177-DOTA-EB-TATE in Adult Patients with Metastatic, Radioactive Iodine Non-Responsive Oncocytic (Hurthle-Cell) Thyroid Cancer
A Study of [Lu-177]Lu-DOTA-TATE in Newly Diagnosed ES-SCLC Patients in Combination with Carboplatin, Etoposide and Atezolizumab
A Study to Assess Safety, Tolerability and Imaging Characteristics of [Ga-68]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [Lu-177]Lu-DPI-4452 in Participants with Unresectable Locally Advanced or Metastatic Solid Tumors
Last update: October 20
Piflufolastat F 18 PET/CT in Patients with Suspected, or at High Risk for Metastatic ccRCC (HARRIER)
Testing the Addition of a New Anti-cancer Drug, Radium-223 Dichloride, to the Usual Treatment (Cabozantinib) for Advanced Renal Cell Cancer That Has Spread to the Bone, RadiCaL Study